Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structure Based Drug Design for HIM Protease: From Molecular Modeling to Cheminformatics

Journal Article · · Curr. Top. Med. Chem.
OSTI ID:1007647
Significant progress over the past decade in virtual representations of molecules and their physicochemical properties has produced new drugs from virtual screening of the structures of single protein molecules by conventional modeling methods. The development of clinical antiviral drugs from structural data for HIV protease has been a major success in structure based drug design. Techniques for virtual screening involve the ranking of the affinity of potential ligands for the target site on a protein. Two main alternatives have been developed: modeling of the target protein with a series of related ligand molecules, and docking molecules from a database to the target protein site. The computational speed and prediction accuracy will depend on the representation of the molecular structure and chemistry, the search or simulation algorithm, and the scoring function to rank the ligands. Moreover, the general challenges in modern computational drug design arise from the profusion of data, including whole genomes of DNA, protein structures, chemical libraries, affinity and pharmacological data. Therefore, software tools are being developed to manage and integrate diverse data, and extract and visualize meaningful relationships. Current areas of research include the development of searchable chemical databases, which requires new algorithms to represent molecules and search for structurally or chemically similar molecules, and the incorporation of machine learning techniques for data mining to improve the accuracy of predictions. Examples will be presented for the virtual screening of drugs that target HIV protease.
Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
USDOE
OSTI ID:
1007647
Journal Information:
Curr. Top. Med. Chem., Journal Name: Curr. Top. Med. Chem. Journal Issue: (10) ; 12, 2007 Vol. 7; ISSN 1568-0266
Country of Publication:
United States
Language:
ENGLISH

Similar Records

Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid
Journal Article · Mon Oct 15 20:00:00 EDT 2018 · Journal of the American Chemical Society · OSTI ID:1483096

Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes
Journal Article · Tue Dec 18 23:00:00 EST 2012 · Biochemical and Biophysical Research Communications · OSTI ID:1061334

Irreversible inhibitors of the HIV protease
Conference · Thu Dec 30 23:00:00 EST 1993 · OSTI ID:141128